Long Acting Injectable Medications Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (First Generation, and Second Generation); End Use (Schizophrenia, Contraception, HIV, and Others), and Geography
Report Code: TIPRE00023213 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Long Acting Injectable Medications Market - By Type
1.3.2 Long Acting Injectable Medications Market - By End Use
1.3.3 Long Acting Injectable Medications Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LONG ACTING INJECTABLE MEDICATIONS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LONG ACTING INJECTABLE MEDICATIONS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LONG ACTING INJECTABLE MEDICATIONS MARKET - GLOBAL MARKET ANALYSIS
6.1. LONG ACTING INJECTABLE MEDICATIONS - GLOBAL MARKET OVERVIEW
6.2. LONG ACTING INJECTABLE MEDICATIONS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. LONG ACTING INJECTABLE MEDICATIONS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. FIRST GENERATION
7.3.1. Overview
7.3.2. First Generation Market Forecast and Analysis
7.4. SECOND GENERATION
7.4.1. Overview
7.4.2. Second Generation Market Forecast and Analysis
8. LONG ACTING INJECTABLE MEDICATIONS MARKET - REVENUE AND FORECASTS TO 2028 - END USE
8.1. OVERVIEW
8.2. END USE MARKET FORECASTS AND ANALYSIS
8.3. SCHIZOPHRENIA
8.3.1. Overview
8.3.2. Schizophrenia Market Forecast and Analysis
8.4. CONTRACEPTION
8.4.1. Overview
8.4.2. Contraception Market Forecast and Analysis
8.5. HIV
8.5.1. Overview
8.5.2. HIV Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. LONG ACTING INJECTABLE MEDICATIONS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Long Acting Injectable Medications Market Overview
9.1.2 North America Long Acting Injectable Medications Market Forecasts and Analysis
9.1.3 North America Long Acting Injectable Medications Market Forecasts and Analysis - By Type
9.1.4 North America Long Acting Injectable Medications Market Forecasts and Analysis - By End Use
9.1.5 North America Long Acting Injectable Medications Market Forecasts and Analysis - By Countries
9.1.5.1 United States Long Acting Injectable Medications Market
9.1.5.1.1 United States Long Acting Injectable Medications Market by Type
9.1.5.1.2 United States Long Acting Injectable Medications Market by End Use
9.1.5.2 Canada Long Acting Injectable Medications Market
9.1.5.2.1 Canada Long Acting Injectable Medications Market by Type
9.1.5.2.2 Canada Long Acting Injectable Medications Market by End Use
9.1.5.3 Mexico Long Acting Injectable Medications Market
9.1.5.3.1 Mexico Long Acting Injectable Medications Market by Type
9.1.5.3.2 Mexico Long Acting Injectable Medications Market by End Use
9.2. EUROPE
9.2.1 Europe Long Acting Injectable Medications Market Overview
9.2.2 Europe Long Acting Injectable Medications Market Forecasts and Analysis
9.2.3 Europe Long Acting Injectable Medications Market Forecasts and Analysis - By Type
9.2.4 Europe Long Acting Injectable Medications Market Forecasts and Analysis - By End Use
9.2.5 Europe Long Acting Injectable Medications Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Long Acting Injectable Medications Market
9.2.5.1.1 Germany Long Acting Injectable Medications Market by Type
9.2.5.1.2 Germany Long Acting Injectable Medications Market by End Use
9.2.5.2 France Long Acting Injectable Medications Market
9.2.5.2.1 France Long Acting Injectable Medications Market by Type
9.2.5.2.2 France Long Acting Injectable Medications Market by End Use
9.2.5.3 Italy Long Acting Injectable Medications Market
9.2.5.3.1 Italy Long Acting Injectable Medications Market by Type
9.2.5.3.2 Italy Long Acting Injectable Medications Market by End Use
9.2.5.4 Spain Long Acting Injectable Medications Market
9.2.5.4.1 Spain Long Acting Injectable Medications Market by Type
9.2.5.4.2 Spain Long Acting Injectable Medications Market by End Use
9.2.5.5 United Kingdom Long Acting Injectable Medications Market
9.2.5.5.1 United Kingdom Long Acting Injectable Medications Market by Type
9.2.5.5.2 United Kingdom Long Acting Injectable Medications Market by End Use
9.2.5.6 Rest of Europe Long Acting Injectable Medications Market
9.2.5.6.1 Rest of Europe Long Acting Injectable Medications Market by Type
9.2.5.6.2 Rest of Europe Long Acting Injectable Medications Market by End Use
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Long Acting Injectable Medications Market Overview
9.3.2 Asia-Pacific Long Acting Injectable Medications Market Forecasts and Analysis
9.3.3 Asia-Pacific Long Acting Injectable Medications Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Long Acting Injectable Medications Market Forecasts and Analysis - By End Use
9.3.5 Asia-Pacific Long Acting Injectable Medications Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Long Acting Injectable Medications Market
9.3.5.1.1 Australia Long Acting Injectable Medications Market by Type
9.3.5.1.2 Australia Long Acting Injectable Medications Market by End Use
9.3.5.2 China Long Acting Injectable Medications Market
9.3.5.2.1 China Long Acting Injectable Medications Market by Type
9.3.5.2.2 China Long Acting Injectable Medications Market by End Use
9.3.5.3 India Long Acting Injectable Medications Market
9.3.5.3.1 India Long Acting Injectable Medications Market by Type
9.3.5.3.2 India Long Acting Injectable Medications Market by End Use
9.3.5.4 Japan Long Acting Injectable Medications Market
9.3.5.4.1 Japan Long Acting Injectable Medications Market by Type
9.3.5.4.2 Japan Long Acting Injectable Medications Market by End Use
9.3.5.5 South Korea Long Acting Injectable Medications Market
9.3.5.5.1 South Korea Long Acting Injectable Medications Market by Type
9.3.5.5.2 South Korea Long Acting Injectable Medications Market by End Use
9.3.5.6 Rest of Asia-Pacific Long Acting Injectable Medications Market
9.3.5.6.1 Rest of Asia-Pacific Long Acting Injectable Medications Market by Type
9.3.5.6.2 Rest of Asia-Pacific Long Acting Injectable Medications Market by End Use
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Long Acting Injectable Medications Market Overview
9.4.2 Middle East and Africa Long Acting Injectable Medications Market Forecasts and Analysis
9.4.3 Middle East and Africa Long Acting Injectable Medications Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Long Acting Injectable Medications Market Forecasts and Analysis - By End Use
9.4.5 Middle East and Africa Long Acting Injectable Medications Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Long Acting Injectable Medications Market
9.4.5.1.1 South Africa Long Acting Injectable Medications Market by Type
9.4.5.1.2 South Africa Long Acting Injectable Medications Market by End Use
9.4.5.2 Saudi Arabia Long Acting Injectable Medications Market
9.4.5.2.1 Saudi Arabia Long Acting Injectable Medications Market by Type
9.4.5.2.2 Saudi Arabia Long Acting Injectable Medications Market by End Use
9.4.5.3 U.A.E Long Acting Injectable Medications Market
9.4.5.3.1 U.A.E Long Acting Injectable Medications Market by Type
9.4.5.3.2 U.A.E Long Acting Injectable Medications Market by End Use
9.4.5.4 Rest of Middle East and Africa Long Acting Injectable Medications Market
9.4.5.4.1 Rest of Middle East and Africa Long Acting Injectable Medications Market by Type
9.4.5.4.2 Rest of Middle East and Africa Long Acting Injectable Medications Market by End Use
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Long Acting Injectable Medications Market Overview
9.5.2 South and Central America Long Acting Injectable Medications Market Forecasts and Analysis
9.5.3 South and Central America Long Acting Injectable Medications Market Forecasts and Analysis - By Type
9.5.4 South and Central America Long Acting Injectable Medications Market Forecasts and Analysis - By End Use
9.5.5 South and Central America Long Acting Injectable Medications Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Long Acting Injectable Medications Market
9.5.5.1.1 Brazil Long Acting Injectable Medications Market by Type
9.5.5.1.2 Brazil Long Acting Injectable Medications Market by End Use
9.5.5.2 Argentina Long Acting Injectable Medications Market
9.5.5.2.1 Argentina Long Acting Injectable Medications Market by Type
9.5.5.2.2 Argentina Long Acting Injectable Medications Market by End Use
9.5.5.3 Rest of South and Central America Long Acting Injectable Medications Market
9.5.5.3.1 Rest of South and Central America Long Acting Injectable Medications Market by Type
9.5.5.3.2 Rest of South and Central America Long Acting Injectable Medications Market by End Use
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL LONG ACTING INJECTABLE MEDICATIONS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. LONG ACTING INJECTABLE MEDICATIONS MARKET, KEY COMPANY PROFILES
12.1. ELI LILLY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALKERMES
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. JOHNSON AND JOHNSON
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ZOGENIX
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. DURECT
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MAPI PHARMA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GSK
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MEDINCELL
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. OAKWOOD LABS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NANOMI
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Long Acting Injectable Medications Market - By Type
1.3.2 Long Acting Injectable Medications Market - By End Use
1.3.3 Long Acting Injectable Medications Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LONG ACTING INJECTABLE MEDICATIONS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LONG ACTING INJECTABLE MEDICATIONS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LONG ACTING INJECTABLE MEDICATIONS MARKET - GLOBAL MARKET ANALYSIS
6.1. LONG ACTING INJECTABLE MEDICATIONS - GLOBAL MARKET OVERVIEW
6.2. LONG ACTING INJECTABLE MEDICATIONS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. LONG ACTING INJECTABLE MEDICATIONS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. FIRST GENERATION
7.3.1. Overview
7.3.2. First Generation Market Forecast and Analysis
7.4. SECOND GENERATION
7.4.1. Overview
7.4.2. Second Generation Market Forecast and Analysis
8. LONG ACTING INJECTABLE MEDICATIONS MARKET - REVENUE AND FORECASTS TO 2028 - END USE
8.1. OVERVIEW
8.2. END USE MARKET FORECASTS AND ANALYSIS
8.3. SCHIZOPHRENIA
8.3.1. Overview
8.3.2. Schizophrenia Market Forecast and Analysis
8.4. CONTRACEPTION
8.4.1. Overview
8.4.2. Contraception Market Forecast and Analysis
8.5. HIV
8.5.1. Overview
8.5.2. HIV Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. LONG ACTING INJECTABLE MEDICATIONS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Long Acting Injectable Medications Market Overview
9.1.2 North America Long Acting Injectable Medications Market Forecasts and Analysis
9.1.3 North America Long Acting Injectable Medications Market Forecasts and Analysis - By Type
9.1.4 North America Long Acting Injectable Medications Market Forecasts and Analysis - By End Use
9.1.5 North America Long Acting Injectable Medications Market Forecasts and Analysis - By Countries
9.1.5.1 United States Long Acting Injectable Medications Market
9.1.5.1.1 United States Long Acting Injectable Medications Market by Type
9.1.5.1.2 United States Long Acting Injectable Medications Market by End Use
9.1.5.2 Canada Long Acting Injectable Medications Market
9.1.5.2.1 Canada Long Acting Injectable Medications Market by Type
9.1.5.2.2 Canada Long Acting Injectable Medications Market by End Use
9.1.5.3 Mexico Long Acting Injectable Medications Market
9.1.5.3.1 Mexico Long Acting Injectable Medications Market by Type
9.1.5.3.2 Mexico Long Acting Injectable Medications Market by End Use
9.2. EUROPE
9.2.1 Europe Long Acting Injectable Medications Market Overview
9.2.2 Europe Long Acting Injectable Medications Market Forecasts and Analysis
9.2.3 Europe Long Acting Injectable Medications Market Forecasts and Analysis - By Type
9.2.4 Europe Long Acting Injectable Medications Market Forecasts and Analysis - By End Use
9.2.5 Europe Long Acting Injectable Medications Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Long Acting Injectable Medications Market
9.2.5.1.1 Germany Long Acting Injectable Medications Market by Type
9.2.5.1.2 Germany Long Acting Injectable Medications Market by End Use
9.2.5.2 France Long Acting Injectable Medications Market
9.2.5.2.1 France Long Acting Injectable Medications Market by Type
9.2.5.2.2 France Long Acting Injectable Medications Market by End Use
9.2.5.3 Italy Long Acting Injectable Medications Market
9.2.5.3.1 Italy Long Acting Injectable Medications Market by Type
9.2.5.3.2 Italy Long Acting Injectable Medications Market by End Use
9.2.5.4 Spain Long Acting Injectable Medications Market
9.2.5.4.1 Spain Long Acting Injectable Medications Market by Type
9.2.5.4.2 Spain Long Acting Injectable Medications Market by End Use
9.2.5.5 United Kingdom Long Acting Injectable Medications Market
9.2.5.5.1 United Kingdom Long Acting Injectable Medications Market by Type
9.2.5.5.2 United Kingdom Long Acting Injectable Medications Market by End Use
9.2.5.6 Rest of Europe Long Acting Injectable Medications Market
9.2.5.6.1 Rest of Europe Long Acting Injectable Medications Market by Type
9.2.5.6.2 Rest of Europe Long Acting Injectable Medications Market by End Use
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Long Acting Injectable Medications Market Overview
9.3.2 Asia-Pacific Long Acting Injectable Medications Market Forecasts and Analysis
9.3.3 Asia-Pacific Long Acting Injectable Medications Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Long Acting Injectable Medications Market Forecasts and Analysis - By End Use
9.3.5 Asia-Pacific Long Acting Injectable Medications Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Long Acting Injectable Medications Market
9.3.5.1.1 Australia Long Acting Injectable Medications Market by Type
9.3.5.1.2 Australia Long Acting Injectable Medications Market by End Use
9.3.5.2 China Long Acting Injectable Medications Market
9.3.5.2.1 China Long Acting Injectable Medications Market by Type
9.3.5.2.2 China Long Acting Injectable Medications Market by End Use
9.3.5.3 India Long Acting Injectable Medications Market
9.3.5.3.1 India Long Acting Injectable Medications Market by Type
9.3.5.3.2 India Long Acting Injectable Medications Market by End Use
9.3.5.4 Japan Long Acting Injectable Medications Market
9.3.5.4.1 Japan Long Acting Injectable Medications Market by Type
9.3.5.4.2 Japan Long Acting Injectable Medications Market by End Use
9.3.5.5 South Korea Long Acting Injectable Medications Market
9.3.5.5.1 South Korea Long Acting Injectable Medications Market by Type
9.3.5.5.2 South Korea Long Acting Injectable Medications Market by End Use
9.3.5.6 Rest of Asia-Pacific Long Acting Injectable Medications Market
9.3.5.6.1 Rest of Asia-Pacific Long Acting Injectable Medications Market by Type
9.3.5.6.2 Rest of Asia-Pacific Long Acting Injectable Medications Market by End Use
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Long Acting Injectable Medications Market Overview
9.4.2 Middle East and Africa Long Acting Injectable Medications Market Forecasts and Analysis
9.4.3 Middle East and Africa Long Acting Injectable Medications Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Long Acting Injectable Medications Market Forecasts and Analysis - By End Use
9.4.5 Middle East and Africa Long Acting Injectable Medications Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Long Acting Injectable Medications Market
9.4.5.1.1 South Africa Long Acting Injectable Medications Market by Type
9.4.5.1.2 South Africa Long Acting Injectable Medications Market by End Use
9.4.5.2 Saudi Arabia Long Acting Injectable Medications Market
9.4.5.2.1 Saudi Arabia Long Acting Injectable Medications Market by Type
9.4.5.2.2 Saudi Arabia Long Acting Injectable Medications Market by End Use
9.4.5.3 U.A.E Long Acting Injectable Medications Market
9.4.5.3.1 U.A.E Long Acting Injectable Medications Market by Type
9.4.5.3.2 U.A.E Long Acting Injectable Medications Market by End Use
9.4.5.4 Rest of Middle East and Africa Long Acting Injectable Medications Market
9.4.5.4.1 Rest of Middle East and Africa Long Acting Injectable Medications Market by Type
9.4.5.4.2 Rest of Middle East and Africa Long Acting Injectable Medications Market by End Use
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Long Acting Injectable Medications Market Overview
9.5.2 South and Central America Long Acting Injectable Medications Market Forecasts and Analysis
9.5.3 South and Central America Long Acting Injectable Medications Market Forecasts and Analysis - By Type
9.5.4 South and Central America Long Acting Injectable Medications Market Forecasts and Analysis - By End Use
9.5.5 South and Central America Long Acting Injectable Medications Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Long Acting Injectable Medications Market
9.5.5.1.1 Brazil Long Acting Injectable Medications Market by Type
9.5.5.1.2 Brazil Long Acting Injectable Medications Market by End Use
9.5.5.2 Argentina Long Acting Injectable Medications Market
9.5.5.2.1 Argentina Long Acting Injectable Medications Market by Type
9.5.5.2.2 Argentina Long Acting Injectable Medications Market by End Use
9.5.5.3 Rest of South and Central America Long Acting Injectable Medications Market
9.5.5.3.1 Rest of South and Central America Long Acting Injectable Medications Market by Type
9.5.5.3.2 Rest of South and Central America Long Acting Injectable Medications Market by End Use
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL LONG ACTING INJECTABLE MEDICATIONS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. LONG ACTING INJECTABLE MEDICATIONS MARKET, KEY COMPANY PROFILES
12.1. ELI LILLY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALKERMES
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. JOHNSON AND JOHNSON
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ZOGENIX
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. DURECT
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MAPI PHARMA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GSK
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MEDINCELL
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. OAKWOOD LABS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NANOMI
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Eli Lilly
2. Alkermes
3. Johnson and Johnson
4. Zogenix
5. DURECT
6. Mapi Pharma
7. GSK
8. MedinCell
9. Oakwood Labs
10. Nanomi
11. Pharmathen
12. Kashiv BioSciences
1. Eli Lilly
2. Alkermes
3. Johnson and Johnson
4. Zogenix
5. DURECT
6. Mapi Pharma
7. GSK
8. MedinCell
9. Oakwood Labs
10. Nanomi
11. Pharmathen
12. Kashiv BioSciences
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount